195 related articles for article (PubMed ID: 15958870)
1. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
Houston MC; Basile J; Bestermann WH; Egan B; Lackland D; Hawkins RG; Moore MA; Reed J; Rogers P; Wise D; Ferrario CM
Am J Med Sci; 2005 Jun; 329(6):276-91. PubMed ID: 15958870
[TBL] [Abstract][Full Text] [Related]
2. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.
Johnson ML; Pietz K; Battleman DS; Beyth RJ
Am J Manag Care; 2004 Dec; 10(12):926-32. PubMed ID: 15617368
[TBL] [Abstract][Full Text] [Related]
4. The individual components of the metabolic syndrome: is there a raison d'etre?
Reaven GM
J Am Coll Nutr; 2007 Jun; 26(3):191-5. PubMed ID: 17634163
[No Abstract] [Full Text] [Related]
5. COSEHC global vascular risk management quality improvement program: rationale and design.
Ferrario CM; Moore MA; Bestermann W; Colby C; Exuzides A; Simmons D; Panjabi S
Vasc Health Risk Manag; 2010; 6():1135-45. PubMed ID: 21931496
[TBL] [Abstract][Full Text] [Related]
6. Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis.
Mirmiran P; Esmaillzadeh A; Azizi F
Eur J Clin Nutr; 2004 Aug; 58(8):1110-8. PubMed ID: 15280905
[TBL] [Abstract][Full Text] [Related]
7. A major health hazard: the metabolic syndrome.
Isomaa B
Life Sci; 2003 Sep; 73(19):2395-411. PubMed ID: 12954449
[TBL] [Abstract][Full Text] [Related]
8. Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science.
Saylor J
Dimens Crit Care Nurs; 2005; 24(2):64-9. PubMed ID: 15827427
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension.
Eaton CB; Feldman HA; Assaf AR; McPhillips JB; Hume AL; Lasater TM; Levinson P; Carleton RA
J Fam Pract; 1994 Jan; 38(1):17-23. PubMed ID: 8289046
[TBL] [Abstract][Full Text] [Related]
10. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
11. Role of hypertension in the metabolic syndrome: who is affected?
Velarde G; Berk BC
Curr Hypertens Rep; 2005 Dec; 7(6):418-26. PubMed ID: 16386197
[TBL] [Abstract][Full Text] [Related]
12. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
Chen J; Townsend RR
Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome as a prohypertensive state.
Mulé G; Cerasola G
Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
[No Abstract] [Full Text] [Related]
14. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit?
Reaven GM
Diabetes Care; 2004 Apr; 27(4):1011-2. PubMed ID: 15047666
[No Abstract] [Full Text] [Related]
15. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
Hanna FW
Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
[No Abstract] [Full Text] [Related]
16. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
Ukkola O
Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.
Shmulewitz D; Auerbach SB; Lehner T; Blundell ML; Winick JD; Youngman LD; Skilling V; Heath SC; Ott J; Stoffel M; Breslow JL; Friedman JM
Hum Hered; 2001; 51(1-2):8-19. PubMed ID: 11096265
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome and cardiovascular disease: Part I.
Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: cardiovascular risk assessment and management.
Wong ND
Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
[TBL] [Abstract][Full Text] [Related]
20. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
